While AD is classically defined by Aβ and tau pathology, neuroinflammation, and synaptic loss, growing evidence suggests that a degree of biological plasticity is maintained throughout the course of the disease (Bhembre et al. 2023; Fan et al. 2025). Here, MAPT is linked to Alzheimer disease.